Rabia Gurses Ozden - Net Worth and Insider Trading
Rabia Gurses Ozden Net Worth
The estimated net worth of Rabia Gurses Ozden is at least $2 Million dollars as of 2024-11-29. Rabia Gurses Ozden is the Chief Medical Officer of Ocular Therapeutix Inc and owns about 153,054 shares of Ocular Therapeutix Inc (OCUL) stock worth over $2 Million. Details can be seen in Rabia Gurses Ozden's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rabia Gurses Ozden has not made any transactions after 2024-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rabia Gurses Ozden
Rabia Gurses Ozden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rabia Gurses Ozden owns 3 companies in total, including Akouos Inc (AKUS) , Adverum Biotechnologies Inc (ADVM) , and Ocular Therapeutix Inc (OCUL) .
Click here to see the complete history of Rabia Gurses Ozden’s form 4 insider trades.
Insider Ownership Summary of Rabia Gurses Ozden
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKUS | Akouos Inc | 2020-06-25 | Chief Development Officer |
| ADVM | Adverum Biotechnologies Inc | 2022-03-17 | director |
| OCUL | Ocular Therapeutix Inc | 2024-02-05 | Chief Medical Officer |
Rabia Gurses Ozden Latest Holdings Summary
Rabia Gurses Ozden currently owns a total of 1 stock. Rabia Gurses Ozden owns 153,054 shares of Ocular Therapeutix Inc (OCUL) as of February 5, 2024, with a value of $2 Million.
Latest Holdings of Rabia Gurses Ozden
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2024-02-05 | 153,054 | 10.06 | 1,539,723 |
Holding Weightings of Rabia Gurses Ozden
Rabia Gurses Ozden Form 4 Trading Tracker
According to the SEC Form 4 filings, Rabia Gurses Ozden has made a total of 4 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Ocular Therapeutix Inc is the sale of 6,346 shares on February 5, 2024, which brought Rabia Gurses Ozden around $30,842.
Insider Trading History of Rabia Gurses Ozden
- 1
Rabia Gurses Ozden Trading Performance
Rabia Gurses Ozden Ownership Network
Rabia Gurses Ozden Owned Company Details
What does Akouos Inc do?
Who are the key executives at Akouos Inc?
Rabia Gurses Ozden is the Chief Development Officer of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .
Akouos Inc (AKUS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akouos Inc Insider Transactions
Rabia Gurses Ozden Mailing Address
Above is the net worth, insider trading, and ownership report for Rabia Gurses Ozden. You might contact Rabia Gurses Ozden via mailing address: C/o Akouos, Inc., 645 Summer Street Suite 200, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
